Italia Markets closed

Incyte Corporation (0J9P.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
72,11+0,85 (+1,20%)
Alla chiusura: 06:20PM BST
Schermo intero
Chiusura precedente71,26
Aperto71,28
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno71,28 - 72,11
Intervallo di 52 settimane71,28 - 72,11
Volume248
Media VolumeN/D
Capitalizzazione15,72B
Beta (5 anni mensile)0,73
Rapporto PE (ttm)N/D
EPS (ttm)-1,36
Prossima data utili01 mag 2023 - 05 mag 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil

    MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for tafasitamab in combination with lenalidomide to ANVISA, the Brazilian health regulatory agency, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for auto